Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pre-Holiday Savings: Device Firms Prepare For Repatriation Tax Bonanza

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson intends to "repatriate" as much as $10 bil. held by foreign subsidiaries following President Bush's Oct. 22 signing of the "JOBS" bill into law

You may also be interested in...



Bausch & Lomb To Compete In Silicone Hydrogel Lens Market With PureVision

Bausch & Lomb predicts that a recent increase in manufacturing capacity will allow its PureVision SVS line of silicone hydrogel contact lenses to take market share from Ciba Vision and Johnson & Johnson/Vistakon

Bausch & Lomb To Compete In Silicone Hydrogel Lens Market With PureVision

Bausch & Lomb predicts that a recent increase in manufacturing capacity will allow its PureVision SVS line of silicone hydrogel contact lenses to take market share from Ciba Vision and Johnson & Johnson/Vistakon

Financings In Brief

InTouch Health: Santa Barbara, Calif.-based firm will use proceeds from a $12.1 mil. Series C financing for ongoing product development and expansion of its sales and marketing team. The firm recently launched its RP-7 remote presence robotic system. The funding was led by Galen Partners, which will contribute two board members, as well as existing investors Acacia Venture Partners and InvestCare Partners. InTouch founder Yulan Wang previously founded robotics company Computer Motion, which merged with Intuitive Surgical in 2003...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel